Porphyria Rare Disease Clinical Research Consortium (RDCRC)
卟啉症罕见病临床研究联盟 (RDCRC)
基本信息
- 批准号:7680477
- 负责人:
- 金额:$ 102.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:AlabamaAmericanBiological ProductsCaliforniaClinicalClinical InvestigatorClinical ResearchClinical TrialsCommunity HealthDevelopmentDiagnosisDiseaseDoctor of PhilosophyFoundationsFundingFutureGeneticGenomicsGrantInborn Genetic DiseasesIndustryInstitutionMedicalMedicinePatient EducationPatient advocacyPatientsPorphyriasPreventive MedicinePrincipal InvestigatorRare DiseasesResearchResearch PersonnelResourcesSan FranciscoScienceSiteSourceSupport GroupsTexasTimeTrainingUnited StatesUniversitiesUtahadvocacy organizationscareer developmentheme biosynthesisimprovedmedical schoolsnext generationnovelprofessorprogramspublic health relevance
项目摘要
DESCRIPTION (provided by applicant): We propose to establish a Rare Diseases Clinical Research Consortium (RDCRC) as a part of the Rare Disease Clinical Research Network (RDCRN) that will focus on the inborn errors of heme biosynthesis, the Porphyrias. The RDCRC will initially bring together the complementary strengths of senior porphyria experts at five regional centers, the American Porphyria Foundation (APF), the porphyria patient advocacy and support group, and biopharmaceutical companies improving and/or developing novel therapies. All five centers are at academic institutions that have NIH-funded CTSAs [University of California, San Francisco (UCSF), University of Alabama, Birmingham (UAB), and the University of Utah (UoU)], or GCRCs [University of Texas Medical Branch, Galveston (UTMB), and The Mount Sinai School of Medicine (MSSM)]. The porphyria experts at these centers comprise an already interactive and interdisciplinary team of translational and clinical investigators who have active basic and clinical porphyria research programs, a strong track record for training young investigators, and internationally recognized clinical expertise. Their combined resources and expertise will advance clinical research in the porphyrias through the clinical studies and trials described in this application. We also propose to train the next generation of clinical and translational porphyria experts, supported in part by this grant and a $1 million matching grant donated by patients and industry to the APF. The Principal and Co-Principal Investigators will be Robert J. Desnick, PhD, MD, Professor and Chair of Genetics and Genomic Sciences at MSSM and Karl E. Anderson, MD, Professor of Preventive Medicine and Community Health at UTMB, respectively. The three other Con- sortium sites will be directed by D. Montgomery Bissell, MD, Professor of Medicine at UCSF, Joseph R. Bloomer, MD, Professor of Medicine at UAB, and James P. Kushner, MD, Professor of Medicine at UoU. Additional affiliate centers will be included over time as funding permits, including support from other grants and philanthropic sources. PUBLIC HEALTH RELEVANCE: The proposed Porphyria RDCRC will bring together senior porphyria experts at five academic institutions; the American Porphyria Foundation (APF), the only patient education, support, and advocacy organization in the United States; and Industry to carry out clinical studies and clinical trials to accelerate the development of improved diagnosis and treatment for the patients with these rare diseases. In addition, the proposed RDCRC will provide the training and career development of the next generation of porphyria clinical investigators who will insure future advances for patients with these diseases.
描述(由申请人提供):我们建议建立一个罕见疾病临床研究联盟(RDCRC),作为罕见疾病临床研究网络(RDCRN)的一部分,该网络将专注于血红素生物合成的先天错误,即卟啉症。RDCRC最初将汇集五个地区中心、美国波特病基金会(APF)、波特病患者倡导和支持团体以及正在改进和/或开发新疗法的生物制药公司的高级波特病专家的互补优势。所有五个中心都位于学术机构,这些机构拥有NIH资助的CTSA[加州大学旧金山分校(UCSF)、阿拉巴马大学伯明翰分校(UAB)和犹他大学(Uou)],或GCRC[德克萨斯大学医学分校加尔维斯顿分校(UTMB)和西奈山医学院(MSSM)]。这些中心的卟啉病专家包括一支由翻译和临床研究人员组成的已经具有互动性和跨学科的团队,他们拥有积极的基础和临床研究计划,在培训年轻研究人员方面有良好的记录,以及国际公认的临床专业知识。他们的联合资源和专业知识将通过本申请中描述的临床研究和试验来推动对卟啉病的临床研究。我们还建议培训下一代临床和转化性卟啉专家,部分由这笔赠款和患者和行业向APF捐赠的100万美元配对赠款支持。首席和联合首席研究员将分别是MSSM遗传学和基因组科学系教授兼主任罗伯特·J·德斯尼克博士和UTMB预防医学和社区健康教授卡尔·E·安德森博士。其他三个Con-sortium网站将由加州大学旧金山分校的医学教授D.Montgomery Bissell、UAB的医学教授Joseph R.Blomer和UOU的医学教授James P.Kushner指导。随着时间的推移,将包括更多的附属中心作为资金许可,包括来自其他赠款和慈善来源的支持。与公共卫生相关:拟议的Porporria RDCRC将汇集五个学术机构的资深Porporria专家;美国Porporria基金会(APF),美国唯一的患者教育、支持和倡导组织;以及产业界开展临床研究和临床试验,以加速改进对这些罕见疾病患者的诊断和治疗。此外,拟议的RDCRC将为下一代卟啉病临床研究人员提供培训和职业发展,他们将确保这些疾病患者未来的进步。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert J Desnick其他文献
520 RAPID PRENATAL DIAGNOSIS OF FABRY'S DISEASE
- DOI:
10.1203/00006450-197804001-00525 - 发表时间:
1978-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Robert J Desnick;Raman M Reddy - 通讯作者:
Raman M Reddy
Alpha-L-iduronidase Deficiency in a Cat: A Model of Mucopolysaccharidosis I
猫的α-L-艾杜糖苷酶缺乏症:黏多糖贮积症 I 型的一个模型
- DOI:
10.1203/00006450-197911000-00018 - 发表时间:
1979-11-01 - 期刊:
- 影响因子:3.100
- 作者:
Mark E Haskins;Peter F Jezyk;Robert J Desnick;Susan K Mcdonough;Donald F Patterson - 通讯作者:
Donald F Patterson
ENZYME MANIPULATION: EVALUATION OF ORAL ZnSO4 SUP-PLEMENTATION IN MANNOSIDOSIS TYPE II
- DOI:
10.1203/00006450-197704000-00520 - 发表时间:
1977-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Gregory A Grabowski;Linda L Walling;Justus U Ikonne;Leonhard S Wolfe;Robert J Desnick - 通讯作者:
Robert J Desnick
From Hereditary Cancer Syndrome to Sporadic Cancer Etiology: Genetic Linkage of DMS-MFH to Chromosome 9p21-22 • 724
- DOI:
10.1203/00006450-199804001-00745 - 发表时间:
1998-04-01 - 期刊:
- 影响因子:3.100
- 作者:
John A Martignetti;Robert J Desnick;Bruce D Gelb - 通讯作者:
Bruce D Gelb
Mannosidosis: Clinical, Morphologic, Immunologic, and Biochemical Studies
- DOI:
10.1203/00006450-197612000-00008 - 发表时间:
1976-12-01 - 期刊:
- 影响因子:3.100
- 作者:
Robert J Desnick;Harvey L Sharp;Gregory A Grabowski;Richard D Brunning;Paul G Quie;Joo H Sung;Robert J Gorlin;Justus U Ikonne - 通讯作者:
Justus U Ikonne
Robert J Desnick的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert J Desnick', 18)}}的其他基金
Administrative Core for the Porphyrias Consortium
卟啉症联盟的行政核心
- 批准号:
10019516 - 财政年份:2009
- 资助金额:
$ 102.89万 - 项目类别:
Administrative Core for the Porphyrias Consortium
卟啉症联盟的行政核心
- 批准号:
10251217 - 财政年份:2009
- 资助金额:
$ 102.89万 - 项目类别:
Porphyria Rare Disease Clinical Research Consortium (RDCRC)
卟啉症罕见病临床研究联盟 (RDCRC)
- 批准号:
8765263 - 财政年份:2009
- 资助金额:
$ 102.89万 - 项目类别:
Administrative Core for the Porphyrias Consortium
卟啉症联盟的行政核心
- 批准号:
10701880 - 财政年份:2009
- 资助金额:
$ 102.89万 - 项目类别:
Porphyria Rare Disease Clinical Research Consortium (RDCRC)
卟啉症罕见病临床研究联盟 (RDCRC)
- 批准号:
8733795 - 财政年份:2009
- 资助金额:
$ 102.89万 - 项目类别:
Porphyria Rare Disease Clinical Research Consortium (RDCRC)
卟啉症罕见病临床研究联盟 (RDCRC)
- 批准号:
8545582 - 财政年份:2009
- 资助金额:
$ 102.89万 - 项目类别:
Porphyria Rare Disease Clinical Research Consortium (RDCRC)
卟啉症罕见病临床研究联盟 (RDCRC)
- 批准号:
8934078 - 财政年份:2009
- 资助金额:
$ 102.89万 - 项目类别:
相似海外基金
Collaborative Research: REU Site: Earth and Planetary Science and Astrophysics REU at the American Museum of Natural History in Collaboration with the City University of New York
合作研究:REU 地点:地球与行星科学和天体物理学 REU 与纽约市立大学合作,位于美国自然历史博物馆
- 批准号:
2348998 - 财政年份:2025
- 资助金额:
$ 102.89万 - 项目类别:
Standard Grant
Collaborative Research: REU Site: Earth and Planetary Science and Astrophysics REU at the American Museum of Natural History in Collaboration with the City University of New York
合作研究:REU 地点:地球与行星科学和天体物理学 REU 与纽约市立大学合作,位于美国自然历史博物馆
- 批准号:
2348999 - 财政年份:2025
- 资助金额:
$ 102.89万 - 项目类别:
Standard Grant
Understanding Latin American Challenges in the 21st Century (LAC-EU)
了解拉丁美洲在 21 世纪面临的挑战 (LAC-EU)
- 批准号:
EP/Y034694/1 - 财政年份:2024
- 资助金额:
$ 102.89万 - 项目类别:
Research Grant
Conference: North American High Order Methods Con (NAHOMCon)
会议:北美高阶方法大会 (NAHOMCon)
- 批准号:
2333724 - 财政年份:2024
- 资助金额:
$ 102.89万 - 项目类别:
Standard Grant
Collaborative Research: RUI: Continental-Scale Study of Jura-Cretaceous Basins and Melanges along the Backbone of the North American Cordillera-A Test of Mesozoic Subduction Models
合作研究:RUI:北美科迪勒拉山脊沿线汝拉-白垩纪盆地和混杂岩的大陆尺度研究——中生代俯冲模型的检验
- 批准号:
2346565 - 财政年份:2024
- 资助金额:
$ 102.89万 - 项目类别:
Standard Grant
REU Site: Research Experiences for American Leadership of Industry with Zero Emissions by 2050 (REALIZE-2050)
REU 网站:2050 年美国零排放工业领先地位的研究经验 (REALIZE-2050)
- 批准号:
2349580 - 财政年份:2024
- 资助金额:
$ 102.89万 - 项目类别:
Standard Grant
Collaborative Research: RUI: Continental-Scale Study of Jura-Cretaceous Basins and Melanges along the Backbone of the North American Cordillera-A Test of Mesozoic Subduction Models
合作研究:RUI:北美科迪勒拉山脊沿线汝拉-白垩纪盆地和混杂岩的大陆尺度研究——中生代俯冲模型的检验
- 批准号:
2346564 - 财政年份:2024
- 资助金额:
$ 102.89万 - 项目类别:
Standard Grant
Conference: Latin American School of Algebraic Geometry
会议:拉丁美洲代数几何学院
- 批准号:
2401164 - 财政年份:2024
- 资助金额:
$ 102.89万 - 项目类别:
Standard Grant
Collaborative Research: Ionospheric Density Response to American Solar Eclipses Using Coordinated Radio Observations with Modeling Support
合作研究:利用协调射电观测和建模支持对美国日食的电离层密度响应
- 批准号:
2412294 - 财政年份:2024
- 资助金额:
$ 102.89万 - 项目类别:
Standard Grant
Conference: Doctoral Consortium at Student Research Workshop at the Annual Conference of the North American Chapter of the Association for Computational Linguistics (NAACL)
会议:计算语言学协会 (NAACL) 北美分会年会学生研究研讨会上的博士联盟
- 批准号:
2415059 - 财政年份:2024
- 资助金额:
$ 102.89万 - 项目类别:
Standard Grant